Biotechnology

Life Sciences

Nutraceutical

Mushrooms and Cancer — Can They Help?

When it comes to cancer prevention and support, nature offers more help than we ...

What Is Nerve Growth Factor? (6 Surprising Reasons You ...

Ever feel like your brain isn’t firing on all cylinders? Maybe your memory’s a l...

8 Reasons Your Hair Follicles Have “Stalled” — And How ...

You wash it, brush it, maybe even style it daily… But lately, your hair just isn...

Latest Posts

View All Posts
Pharmaceutical

FDA publishes more than 200 archived CRLs for transparency

The FDA has issued more than 200 complete response letters, which detail reasons...

Pharmaceutical

EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma

BeOne Medicines has secured approval from the EC for Tevimbra (tislelizumab) to ...

Biotechnology

Future Foods: Past Insights Driving SDG-2 Progress

As the global population accelerates towards nearly 10 billion by mid-century, t...

Biotechnology

Predicting Small-Molecule Function via Screening Data A...

In the dynamic arena of drug discovery, high-content image-based phenotypic scre...

Biotechnology

Correcting Insights: Evolution of Leaf Venation Networks

In the ever-evolving landscape of botanical research, the intricate architecture...

Biotechnology

Metabolic Syndrome Links BMI and Depression Trajectories

In a groundbreaking cohort study emerging from China, researchers have explored ...

Life Sciences

AstraZeneca’s Alexion Signs $825 Million Gene Therapy L...

AstraZeneca’s rare disease division, Alexion, has finalized a license agreement ...

Life Sciences

Eli Lilly’s Kisunla Bags FDA Green Light For Alzheimer’...

The benefit-risk ratio looks like it increasingly favours Eli Lilly’s Kisunla in...

Life Sciences

Alcon to Acquire LumiThera and Its FDA-Authorized PBM D...

Alcon has announced its plan to acquire LumiThera, Inc., a company that develope...

Life Sciences

$20 Million Pediatric CRISPR Center Launched to Develop...

A new center dedicated to advancing CRISPR-based treatments for severe genetic c...

Pharmaceutical

Merck agrees to acquire Verona Pharma for $10bn

Merck has entered a definitive agreement to acquire biopharmaceutical company Ve...

Pharmaceutical

Lupin and Zentiva in licence and supply deal for Certol...

Zentiva Group has entered a licence and supply agreement with Lupin for the comm...

12